Publications
CIRS publishes insights from its research and meetings in several forms:
- R&D Briefings – research papers produced by the CIRS team e.g. annual regulatory and HTA benchmarking briefings
- Journal articles – peer reviewed academic research papers
- Reports – from CIRS workshops and externally commissioned research projects, as well as CIRS Annual Reports
- Books – research theses from CIRS-supported PhD students
- Posters – presented at external conferences
Keep up-to-date with CIRS publications and activities by signing up to our mailing list or following CIRS on LinkedIn.
2011 Workshop report – Visualising benefit risk
Visualising benefit risk: The key to developing a framework that informs stakeholder perspective and clarity of decision making 16-17th June 2011, Washington DC, USA In 2010 CIRS held its annual …
2011 Workshop report – Evidentiary requirements in clinical development
Evidentiary requirements in clinical development: Synchronising phase 3 requirements to meet multiple needs 31st March – 1st April 2011, Geneva, Switzerland A drug development programme is by its very nature …
2011 Workshop report – Regional alignment in Asia Pacific
Regional alignment in Asia Pacific: What needs to be in the regulatory science toolkit to enable good regulatory decision making? 26-27th January 2011, Tokyo, Japan Regulatory agencies are rising to …
2010 Workshop report – New development paradigms to facilitate early access
New development paradigms: Building regulatory confidence for the early release of medicines 11-12th October 2010, Surrey, UK Over the last 5 years CIRS workshops have suggested a number of approaches …
2010 Executive Forum report – Refining the benefit-risk framework for the assessment of medicines
Refining the benefit-risk framework for the assessment of medicines: Valuing and weighting benefit and risk parameters 17-18th June 2010, Washington DC, USA Determining the benefit-risk balance of a medicine is …
2010 Workshop report – Review and reimbursement: Aligning the needs and requirements in clinical development
Review and reimbursement: Aligning the needs and requirements in clinical development 23rd-24th March 2010, Washington DC, USA The current dynamics of bringing new medicines to market are being influenced by …
2009 Workshop Report – Acceptability of data generated from foreign clinical trials and ethnic factors in drug development
This CIRS multi-stakeholder workshop examined strategies for incentivising the development of medicines for common chronic diseases.
Liberti et al 2010 – Progress on the development of a benefit-risk framework for evaluating medicines
CIRS authors write about benefit-risk in the March 2010 issue of Regulatory Focus by the Regulatory Affairs Professionals Society (RAPS). Article reproduced with the permission of RAPS. Download
2009 Workshop report – Review and reimbursement: A special case for better co-operation
Review and reimbursement: A special case for better co-operation 29-30th September 2009, Surrey, UK The current dynamics of bringing new medicines to market are influenced by potential conflicts between the …
2009 Workshop report – Strategies for communicating benefits and risks to decision makers
Strategies for communicating benefits and risks to decision makers: Explaining methods, findings and conclusions through a common language approach 17-19th June 2009, Washington DC, USA Determining the benefit-risk (BR) balance …
2009 Workshop report – Expediting patients’ access to medicines: Solutions to simultaneous submissions and approvals
Expediting patients’ access to medicines: Solutions to simultaneous submissions and approvals 20-31 March 2009, Surrey, UK Major companies engaging in global development programmes are currently trying to reduce the development …
2008 Workshop report – Predictable outcomes: Why do potential winners fail?
Predictable outcomes: Why do potential winners fail? 30th September – 1st October 2008, Washington DC, USA A little more than 10% of new compounds that are at the first-human-dose evaluation …
2008 Workshop report – Clinical development in Asia, Africa and Latin America
Clinical development in Asia, Africa and Latin America: Streamlining the procedure for obtaining global clinical trial approvals 1st-2nd December 2008, Intercontinental Hotel, Singapore Is the concept of the simultaneous global …
2008 Workshop report – Measuring benefit and balancing risk
Measuring benefit and balancing risk: Strategies for the benefit-risk assessment of new medicines in a risk-averse environment 19-20th June 2008, Sofitel Lafayette Square, Washington DC, USA Measuring the benefits and …
2008 Workshop report – Knowledge sharing and cooperation
Knowledge sharing and co-operation – Are these the key to a more certain future for pharmaceutical innovation? 29-30th April 2008, Surrey, UK Altruism or enlightened self-interest – what are the …